Increased endogenous dopamine prevents myopia in mice.

Animals Biomarkers / metabolism Disease Models, Animal Dopamine / metabolism Dopamine Agents / pharmacokinetics Female Levodopa / pharmacokinetics Male Mice Mice, Inbred C57BL Myopia / metabolism Refraction, Ocular / physiology Retina / diagnostic imaging Tomography, Optical Coherence
Dopamine Form-deprivation L-DOPA Mouse Myopia Retina VMAT2

Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
04 2020
Historique:
received: 12 09 2019
revised: 31 01 2020
accepted: 01 02 2020
pubmed: 8 2 2020
medline: 11 11 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

Experimental evidence suggests that dopamine (DA) modulates refractive eye growth. We evaluated whether increasing endogenous DA activity using pharmacological or genetic approaches decreased myopia susceptibility in mice. First, we assessed the effects of systemic L-3,4-dihydroxyphenylalanine (L-DOPA) injections on form deprivation myopia (FDM) in C57BL/6 J (WT

Identifiants

DOI: 10.1016/j.exer.2020.107956 PMID: 32032629 PMC: PMC7113116
pubmed: 32032629
pii: S0014-4835(19)30679-7
doi: 10.1016/j.exer.2020.107956
pmc: PMC7113116
mid: NIHMS1561676
pii:
doi:

Substances chimiques

Biomarkers 0
Dopamine Agents 0
Levodopa 46627O600J
Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107956

Subventions

Organisme : NEI NIH HHS
ID : P30 EY006360
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032029
Pays : United States
Organisme : RRD VA
ID : IK6 RX003134
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY016435
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027711
Pays : United States
Organisme : NEI NIH HHS
ID : T32 EY007092
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Références

J Neurosci. 2009 Jun 24;29(25):8103-13
pubmed: 19553450
Curr Biol. 2019 Mar 4;29(5):763-774.e5
pubmed: 30799247
J Neurosci. 2013 Sep 18;33(38):14989-97
pubmed: 24048828
Exp Eye Res. 2013 Sep;114:106-19
pubmed: 23434455
Exp Eye Res. 2007 Jan;84(1):100-7
pubmed: 17094962
Exp Eye Res. 1991 Jun;52(6):755-8
pubmed: 1855549
J Neurosci. 2014 Mar 26;34(13):4627-33
pubmed: 24672008
Exp Eye Res. 2015 Aug;137:79-83
pubmed: 26072023
Exp Eye Res. 2013 Sep;114:48-57
pubmed: 23680160
Fed Proc. 1984 Sep;43(12):2709-13
pubmed: 6147273
Retina. 2017 May;37(5):989-997
pubmed: 27617538
Sci Rep. 2019 Dec 4;9(1):18345
pubmed: 31797988
Optom Vis Sci. 2010 Jan;87(1):53-60
pubmed: 19901858
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):706-12
pubmed: 18235018
Curr Opin Neurobiol. 1998 Jun;8(3):405-12
pubmed: 9687352
J Neurosci. 2012 Jul 4;32(27):9359-68
pubmed: 22764243
Ophthalmic Physiol Opt. 2015 Sep;35(5):465-75
pubmed: 26303444
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3524-32
pubmed: 17652719
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3933-46
pubmed: 12939312
Vis Neurosci. 1993 May-Jun;10(3):447-53
pubmed: 8494798
Exp Eye Res. 2009 Jun;88(6):1092-9
pubmed: 19450449
J Neurosci Methods. 2007 Mar 30;161(1):96-100
pubmed: 17126909
Exp Eye Res. 2010 Nov;91(5):715-20
pubmed: 20801115
Front Biosci. 2008 May 01;13:4904-11
pubmed: 18508555
Invest Ophthalmol Vis Sci. 2014 Sep 02;55(10):6272-9
pubmed: 25183765
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5348-54
pubmed: 19516016
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9977-82
pubmed: 24979780
J Neurosci. 2012 Sep 19;32(38):13281-91
pubmed: 22993444
Exp Eye Res. 2007 Jul;85(1):15-22
pubmed: 17498696
Prog Retin Eye Res. 2018 Jan;62:134-149
pubmed: 28951126
Bull World Health Organ. 2008 Jan;86(1):63-70
pubmed: 18235892
Mol Vis. 2013 Sep 28;19:2068-79
pubmed: 24146540
Prog Retin Eye Res. 2017 Nov;61:60-71
pubmed: 28602573
Invest Ophthalmol Vis Sci. 1991 Apr;32(5):1674-7
pubmed: 2016144
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2623-2634
pubmed: 29847669
ACS Chem Neurosci. 2015 May 20;6(5):790-9
pubmed: 25746685
Science. 1978 Nov 24;202(4370):901-2
pubmed: 30997
Mol Imaging Biol. 2018 Oct;20(5):771-779
pubmed: 29520623
Exp Eye Res. 2013 Sep;114:96-105
pubmed: 23305908
Neuroscience. 2011 Oct 13;193:109-21
pubmed: 21742018
Vis Neurosci. 1997 May-Jun;14(3):493-505
pubmed: 9194316
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):421-8
pubmed: 22169102
Acta Ophthalmol Scand. 2006 Feb;84(1):110-5
pubmed: 16445449
Exp Eye Res. 2016 Apr;145:289-296
pubmed: 26836248
Mol Cell Biol. 2001 Aug;21(16):5321-31
pubmed: 11463816
Ophthalmic Physiol Opt. 2018 May;38(3):217-245
pubmed: 29691928
Ophthalmology. 2018 Aug;125(8):1239-1250
pubmed: 29371008
Biochemistry. 1990 Jan 23;29(3):603-8
pubmed: 2140052
Prog Brain Res. 1993;98:175-81
pubmed: 8248506
Doc Ophthalmol. 2004 Jan;108(1):17-40
pubmed: 15104164
Vision Res. 1995 May;35(9):1247-64
pubmed: 7610585
Vision Res. 2004;44(16):1857-67
pubmed: 15145680
Br J Ophthalmol. 2018 Jul;102(7):855-862
pubmed: 29699985
Vision Res. 1997 Mar;37(6):659-68
pubmed: 9156210
Optom Vis Sci. 2004 Feb;81(2):137-47
pubmed: 15127933
Ophthalmology. 2008 Aug;115(8):1279-85
pubmed: 18294691
Mol Vis. 2014 Sep 20;20:1318-27
pubmed: 25352740
J Comp Neurol. 2005 Jan 24;481(4):352-62
pubmed: 15593337
Proc Natl Acad Sci U S A. 1989 Jan;86(2):704-6
pubmed: 2911600
Clin Exp Optom. 2015 Nov;98(6):507-17
pubmed: 26769177
Neurobiol Dis. 2012 Oct;48(1):66-78
pubmed: 22659308
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4412-4419
pubmed: 27750284
Toxicol Sci. 2016 Sep;153(1):79-88
pubmed: 27287315
Cornea. 1999 Nov;18(6):721-8
pubmed: 10571305
J Neurosci. 2007 Jul 25;27(30):8138-48
pubmed: 17652604
Exp Eye Res. 2019 Mar;180:226-230
pubmed: 30605665

Auteurs

E G Landis (EG)

Neuroscience, Emory University, Atlanta, GA, USA; Atlanta Veterans Affairs Healthcare System, Decatur, GA, USA.

M A Chrenek (MA)

Ophthalmology, Emory University, Atlanta, GA, USA.

R Chakraborty (R)

Ophthalmology, Emory University, Atlanta, GA, USA.

R Strickland (R)

Neuroscience, Emory University, Atlanta, GA, USA.

M Bergen (M)

Ophthalmology, Emory University, Atlanta, GA, USA.

V Yang (V)

Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.

P M Iuvone (PM)

Neuroscience, Emory University, Atlanta, GA, USA; Ophthalmology, Emory University, Atlanta, GA, USA.

M T Pardue (MT)

Neuroscience, Emory University, Atlanta, GA, USA; Ophthalmology, Emory University, Atlanta, GA, USA; Atlanta Veterans Affairs Healthcare System, Decatur, GA, USA; Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA. Electronic address: machelle.pardue@bme.gatech.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures aromatiques › Dérivés du benzène › Phénols › Catéchols › Catécholamines › Dopamine › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents dopaminergiques › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés cycliques › Acides aminés aromatiques › Tyrosine › Dopa › Lévodopa › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Maladies de l'oeil › Troubles de la réfraction oculaire › Myopie › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Phénomènes physiologiques oculaires › Réfraction oculaire › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Organes des sens › Oeil › Rétine › Increased endogenous dopamine prevents myopia in mice.
questionsmedicales.fr › Techniques d'investigation › Imagerie optique › Tomographie optique › Tomographie par cohérence optique › Increased endogenous dopamine prevents myopia in mice.